A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
about
Protective effect of Toll-like receptor 4 in pulmonary vaccinia infectionOncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesOncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase geneThe combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host.Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.Advances in oncolytic virus therapy for glioma.Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma.Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate CancerThe importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.
P2860
Q33370547-CB0B27CF-3F66-4D0D-9F17-D21496ED58DEQ33924550-F97EEE3F-A538-47BE-AA88-2D5599D7A9F5Q34287746-0E28405C-AD07-4521-BF6C-594BED24016CQ34316241-F0B449E0-57C4-4E15-9291-4826E5BBF7AEQ35338417-E32A2237-55D4-4157-9257-B7B1A153781BQ35647212-4FD3DB7E-EEB1-4A4D-91E5-72EF5CAFDF92Q36049446-D9554D5C-3F8A-4894-9712-18E9690B4BFEQ36922264-2BDDBC58-6934-4123-B846-6DD0A89A7AD9Q37287118-D21DB58F-07C1-474F-8BF8-6BF06D6E0208Q38673968-5D769FB8-9505-4378-B87F-9F7BF09CECF3Q39452616-C7E3417D-BB3B-4FD0-8750-BE1C13F6268EQ41699675-FA4BFE3F-CE0F-40B2-9880-AD0CCDED41F6Q52594999-C5C0A53B-42C0-45FA-896B-A118FA951B7F
P2860
A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A new recombinant vaccinia wit ...... fficacy as an oncolytic virus.
@en
type
label
A new recombinant vaccinia wit ...... fficacy as an oncolytic virus.
@en
prefLabel
A new recombinant vaccinia wit ...... fficacy as an oncolytic virus.
@en
P2093
P2860
P356
P1433
P1476
A new recombinant vaccinia wit ...... fficacy as an oncolytic virus.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302914
P577
2007-02-01T00:00:00Z
P5875
P6179
1027413522